[{"AccountsPayableCurrent_0_Q2_USD":14022000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-53000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":15000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-17000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":15000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-17000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":38000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":36000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":406000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_2_Q2_USD":1675000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":35128000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":27856000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-23000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2604000.0,"OperatingIncomeLoss_1_Q2_USD":-70514000.0,"NonoperatingIncomeExpense_2_Q2_USD":277000.0,"NonoperatingIncomeExpense_1_Q2_USD":81000.0,"NetIncomeLoss_2_Q2_USD":-131731000.0,"NetIncomeLoss_1_Q2_USD":-70433000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-119649000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":63455000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11206000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":55605000.0,"MarketableSecurities_0_Q2_USD":304405000.0,"LiabilitiesCurrent_0_Q2_USD":66054000.0,"OperatingIncomeLoss_2_Q2_USD":-132008000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":81000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":277000.0,"PaymentsOfStockIssuanceCosts_2_Q2_USD":40000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":57987095.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":57867795.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":5903000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":1722000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":2658000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":8548000.0,"StockholdersEquity_0_Q2_USD":446656000.0,"SignificantSupplyCommitmentRemainingMinimumAmountCommitted_0_Q2_USD":8600000.0,"ShareBasedCompensation_2_Q2_USD":23490000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":63575000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":32828000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":48729000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":23573000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-886199000.0,"RestrictedInvestmentsNoncurrent_0_Q2_USD":3102000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":115665000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":59984000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9588000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":16033000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":260612000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":2658000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":8588000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":14977000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":1069000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":212121000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":540566000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":57987095.0,"Liabilities_0_Q2_USD":93910000.0,"InventoryWriteDown_2_Q2_USD":100000.0,"CommonStockSharesOutstanding_0_Q2_shares":58033984.0,"CommonStockSharesIssued_0_Q2_shares":58033984.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-44988000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":90947000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":90947000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedLoss_2_Q2_USD":70000.0,"AvailableForSaleDebtSecuritiesGrossUnrealizedGain_2_Q2_USD":56000.0,"AssetsFairValueDisclosure_0_Q2_USD":422129000.0,"CommonStockValue_0_Q2_USD":580000.0,"AssetsCurrent_0_Q2_USD":437143000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7647354.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":23490000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":12371000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":23490000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":12371000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1332249000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":26000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":5433000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":49428000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-847000.0,"AccountsReceivableNetCurrent_0_Q2_USD":18608000.0,"Assets_0_Q2_USD":540566000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-70450000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-131716000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1275000.0,"InventoryWriteDown_1_Q2_USD":0.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":6543000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1352000.0,"InventoryNet_0_Q2_USD":8206000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":311000.0,"IncreaseDecreaseOfRestrictedInvestments_2_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2489000.0,"IncreaseDecreaseInOperatingLeaseLiability_2_Q2_USD":-1223000.0,"IncreaseDecreaseInInventories_2_Q2_USD":4156000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-4536000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":4712000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":1711000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":121700000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":8886000.0,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":38000.0,"EarningsPerShareDiluted_2_Q2_USD":-2.28,"EarningsPerShareDiluted_1_Q2_USD":-1.21,"EarningsPerShareBasic_2_Q2_USD":-2.28,"EarningsPerShareBasic_1_Q2_USD":-1.21,"DepreciationDepletionAndAmortization_2_Q2_USD":1475000.0,"DebtSecuritiesAvailableForSaleExcludingAccruedInterest_0_Q2_USD":360010000.0,"DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_0_Q2_USD":360024000.0,"CostsAndExpenses_2_Q2_USD":180737000.0,"CostsAndExpenses_1_Q2_USD":94087000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":1497000.0,"InvestmentsAndCash_0_Q2_USD":451000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":57867795.0,"Ticker":"DCPH","CIK":"1654151","name":"DECIPHERA PHARMACEUTICALS, INC.","OfficialName":"Deciphera Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"586694767.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210803"}]